Filing metadata

Accession number
0001104659-19-047348
Form type
Form 4/A
Filer
Nabriva Therapeutics plc
CIK
CIK 1641640
Filed
Aug 26, 2019
Reporting period
Aug 21, 2019
Description
Insider transaction

Explore SEC Filings Hub